MIG
LAB icon

Mariner Investment Group’s Standard BioTools LAB Stock Holding History

Mariner Investment Group’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-25,000
Closed -$203K – 221
2015
Q3 		$203K Hold
25,000
– – 0.04% 161
2015
Q2 		$605K Buy
+25,000
New +$789K 0.15% 129

Other funds holding LAB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Mariner Investment Group's LAB Position: Q4 2015 in Review

Mariner Investment Group sold out of Standard BioTools (LAB) in Q4 2015, closing a stake of 25,000 shares — an estimated $203K sold.

Mariner Investment Group first reported a position in LAB in Q2 2015 and held it in 2 quarters. The position peaked at $605K in Q2 2015. 106 funds tracked by Wall St. Rank hold LAB as of Q4 2015.

  • Mariner Investment Group reported no remaining Standard BioTools position as of Q4 2015 after selling out during the quarter.
  • Mariner Investment Group sold 25,000 Standard BioTools shares in Q4 2015, an estimated $203K.
  • Mariner Investment Group first reported a position in Standard BioTools in Q2 2015 and held it in 2 quarters.
  • Mariner Investment Group's Standard BioTools position peaked at $605K in Q2 2015.
  • 106 funds tracked by Wall St. Rank held Standard BioTools as of Q4 2015.

Based on Mariner Investment Group's 13F filing for Q4 2015, filed 2 Feb 2016.